by The phosphor screen scanner market comprises a wide range of products used to digitize X-ray film screens, thereby converting analog medical images into digital formats for processing, storage, and analysis. Phosphor screen scanners help capture high-resolution digital images at remarkable speeds and have enabled a transition from traditional film-based pathology to digital pathology. Key advantages include improved diagnostics due to availability of high-quality digital images, reduced storage costs compared to physical films or slides, integrated workflow solutions, and ability to share images over networks. The increased efficiency and accuracy of diagnosis through digital images is driving demand for phosphor screen scanners across hospitals and diagnostic centers.
The Global Phosphor Screen Scanner Market Size is estimated to be valued at US$ 288 Bn in 2024 and is expected to exhibit a CAGR of 10% over the forecast period between 2024 to 2030.
Key Takeaways
Key players operating in the Phosphor screen scanners are Intomics, GENinCode, NanoString, Tepnel Pharma Services Limited, Pfizer Inc., Novartis AG, Teva Pharmaceutical Industries Ltd., Merck & Co., Inc, QIAGEN, Quest Diagnostics Incorporated, Medtronic, Thermo Fisher Scientific Inc., Laboratory Corporation of America Holdings, bioMérieux SA, F. Hoffmann-La Roche Ltd, Eli Lilly & Company, GlaxoSmithKline plc, Cepheid, AstraZeneca PLC, Myriad Genetics, Inc., Bristol-Myers Squibb Company, and Found. TheGrowing demand for early-stage cancer detection and precise diagnostics is fueling adoption of phosphor screen scanners across healthcare facilities. Phosphor screen scanners enable pathology labs to increase throughput, scale digital capabilities, and expand diagnostic menus to meet rising workload. Major players are investing in R&D to develop advanced digital screening solutions, facilitating the global expansion of the phosphor screen scanner market into emerging economies.
Market key trends
One of the key trends shaping the phosphor screen scanner market is the growing preference for advanced digital pathology solutions over conventional film-based pathology. Digital pathology provides hospitals and diagnostic labs distinct advantages such as computer-assisted diagnostics, integrated workflows, centralized case management systems, and ability to easily archive, retrieve and share whole slide images. Leading companies are focusing on the development of high-throughput scanners integrated with AI and machine learning algorithms to deliver rapid and accurate diagnostics. Such technological advancements are expected to drive continued revenue growth in the global phosphor screen scanner market during the forecast period.
Porter’s Analysis
Threat of new entrants: Low as setup costs are high and existing players have established brand names.
Bargaining power of buyers: High due to availability of alternatives. Bargaining power of suppliers: Low as raw materials are easily available.
Threat of new substitutes: High due to emergence of newer advanced technologies.
Competitive rivalry: Intense as major players focus on expanding their product portfolios through R&D and acquisitions.
The North American region currently holds the largest share of the Phosphor Screen Scanner market in terms of value due to high healthcare expenditure and presence of key market players in the region. The Asia Pacific region is expected to be the fastest growing market for Phosphor Screen Scanners during the forecast period due to increasing awareness, expanding private healthcare sector, and improving healthcare infrastructure in emerging economies like China and India.
*Note:
1.Source: Coherent Market Insights, Public sources, Desk research
2.We have leveraged AI tools to mine information and compile it
